Research and Development Product Pipeline
Arbor Pharmaceuticals has multiple projects under various stages of development. These include products in the cardiovascular, hospital, pediatric and gynecology areas. We develop both new chemical entities as well as already approved molecules for new indications or in improved dosage forms. Our research scientists have extensive experience in clinical development and work collaboratively with the FDA to obtain market approval. The company has already filed two New Drug Applications (NDAs), both of which have been approved and also has several additional products in late stage development. The projects currently in clinical development are shown below.